跳至主要内容
临床试验/NL-OMON51315
NL-OMON51315撤回不适用

Assessing Overall Survival, Quality of Life, Frailty, Comorbidity Indexes, Healthcare Usage, and Pharmacoeconomics in Elderly Patients with Acute Myeloid Leukemia - ZEALOUS-AM

Medisch Centrum Leeuwarden0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 至 99(—)

入选标准

  • Patients in the Dutch province of Friesland may present at any of the 4 Frisian
  • Hospitals. Complicated cases such as elderly patients with AML are referred to
  • the MCL. Patients from outside of the province of Friesland are uncommon.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Age upon diagnosis <= 65 years
  • Patients diagnosed with APL (t(15;17), WHO 2016)

研究者

发起方
Medisch Centrum Leeuwarden

相似试验